🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Muscle Cancer

Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma NCT07169344Phase 24 sites📍 Bergen📍 Oslo📍 Tromsø Oslo University Hospital · Tests: preoperative, Quality of life, Functional outcome FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma NCT04625907Phase 1, Phase 2128 sites📍 Brisbane📍 Camperdown📍 Clayton University of Birmingham · Tests: Irinotecan, Actinomycin D, Doxorubicin, Ifosfamide, Vincristine A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder NCT07475806Phase 266 sites📍 Little Rock📍 Stanford📍 Chicago Astellas Pharma Global Development, Inc. · Tests: Enfortumab Vedotin, Pembrolizumab Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy NCT07386444NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Inspiratory muscle training FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence NCT07647198Phase 21 site📍 Abu Dhabi Sheikh Shakhbout Medical City · Tests: Vitamin D and Green Tea, Placebo Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer NCT05789433NA1 site📍 Orlando AdventHealth Translational Research Institute · Tests: Aerobic exercise, Progressive stretching Preoperative Detection of Muscle Invasion in Bladder Cancer with Contrast-enhanced Ultrasonography NCT05204108n/a1 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy NCT07144319n/a8 sites📍 Tampa📍 Ann Arbor📍 New Brunswick Photocure Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer NCT07474519Phase 41 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Accelerometry, BCG Solution, BCG Solution, BCG Solution, Electronic Health Record Review Metabolism, Circadian Rhythms and Ovarian Function NCT05007834n/a1 site📍 Lille University Hospital, Lille A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy NCT07633756Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: REC617 Differences in Speed of Recovery From Anesthesia for Intraoral Surgery NCT06275087NA1 site📍 Zagreb Clinical Hospital Centre Zagreb · Tests: Propofol, Sevoflurane THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation NCT06395506NA1 site📍 Galveston The University of Texas Medical Branch, Galveston · Tests: Creatine Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection NCT06525571Phase 32 sites📍 Washington D.C.📍 Baltimore Johns Hopkins University · Tests: Cysview, Karl Storz D-Light C Photodynamic Diagnostic (PDD) system Neurosurgical Outcome Network NCT06724029n/a27 sites📍 Bergamo📍 Brescia📍 Brescia Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Comparison of Serum Myokine Dosages and Imaging Methods in the Evaluation of Sarcopenia in Patients With Hepatocellular Carcinoma NCT06475118NA1 site📍 Reims CHU de Reims · Tests: Dynamometry measurement, myokine dosing, sarcopenia calculation A Comparative Study of MRI and Ultrasound for Detection of Primary Hepatocellular Carcinoma, Body Composition and Risk Factors for Decompensation in Liver Cirrhosis NCT07291141n/a1 site📍 Linköping Mattias Ekstedt A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) NCT07222488Phase 1, Phase 217 sites📍 Bakersfield📍 New Brunswick📍 Myrtle Beach Merck Sharp & Dohme LLC · Tests: MK-3120 The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients NCT06406803NA1 site📍 Hasselt Maastricht University Medical Center · Tests: Dietary energy restriction, Daily exercise Chemoablation for Low-Grade Bladder Cancer NCT07019220Phase 21 site📍 Vienna Ekaterina Laukhtina · Tests: Gemcitabine Pioglitazone Therapy Targeting Fatigue in Breast Cancer NCT05013255Phase 21 site📍 Morgantown West Virginia University · Tests: Pioglitazone 15mg, Pioglitazone 30 mg Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer NCT06995677Phase 248 sites📍 Homewood📍 Little Rock📍 Murrieta Tyra Biosciences, Inc · Tests: TYRA-300 60mg, TYRA-300 50mg, TYRA-300 Dose 70 mg Deep Neuromuscular Blockade and a Low-Residue Diet for the Surgical Field in vNOTES Hysterectomy NCT07730970NA3 sites📍 Istanbul📍 Istanbul📍 Kütahya Fatih Sultan Mehmet Training and Research Hospital · Tests: Deep Neuromuscular Blockade (NMB), Standard (moderate) neuromuscular blockade, Preoperative low-residue diet Morphological Changes of Upper Trapezius Muscle After Physotherapy in Oral Cancer NCT07166575n/a1 site📍 Taipei National Taiwan University Hospital · Tests: B-mode ultrasonography MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma NCT06277154Phase 21 site📍 Guangzhou HRYZ Biotech Co. · Tests: MASCT-I, Doxorubicin, Ifosfamide Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer NCT07646145Phase 21 site📍 Taiyuan Shanxi Province Cancer Hospital · Tests: Disitamab Vedotin, Mitomycin C (MMC) Skeletal Muscle Mass Changes on Images for Prediction of Prognosis After Exercise Training in HNSCC Patients NCT06666881NA1 site📍 New Taipei City Chang Gung Memorial Hospital · Tests: HIIT only, HIIT & Record of physical activities at home. Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU NCT05500118n/a1 site📍 Shenzhen Shenzhen Maternity & Child Healthcare Hospital · Tests: Patients Decision Aids Post-contracture Release Radiation for Dupuytren's Disease NCT04122313n/a1 site📍 Minneapolis University of Minnesota · Tests: Evaluation of Dupuytren's Disease Treatment Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology NCT06392997n/a13 sites📍 Angers📍 Bordeaux📍 Bordeaux ZIWIG · Tests: Saliva sample
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy